Dr. James Norman Atkins, MD

  • North Wilkesboro, NC
  • Hematologist and oncologist
NPI1104808476PAC ID3173656345
Medicare services, 2024
528
Medicare patients, 2024
246
Part D claims, 2024
1,041
Publications
37
Clinical trials
10
Practice address
1370 West D St, North Wilkesboro, NC 28659
Practice phone
Call (336) 651-8100
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Wilkes Medical Center

Hospital · North Wilkesboro, North Carolina

See all 7 affiliations

Find Dr. Atkins' professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. James Norman Atkins is a hematologist and oncologist in North Wilkesboro, North Carolina

Dr. Atkins practices at Wilkes Medical Center in North Wilkesboro, North Carolina, part of Advocate Health.

Dr. Atkins' NPI, 1104808476, was assigned on November 14, 2005. Dr. Atkins holds North Carolina license 22209.

NPI and contact details
Medicare PAC ID
3173656345
NPI enumeration date
November 14, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(336) 651-8100
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
76
Medical school graduation
1976

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. James Norman Atkins practices at Wilkes Medical Center in North Wilkesboro, North Carolina

Dr. Atkins' primary practice is Wilkes Medical Center, at 1370 West D St, North Wilkesboro, NC 28659 in Wilkes County. The practice phone is (336) 651-8100.

  • Wilkes Medical Center
    1370 West D St, North Wilkesboro, NC 28659 · Wilkes CountyPhone(336) 651-8100

Source: Dmand AI Affiliation Data

Dr. James Norman Atkins is affiliated with 5 sites of care and 2 medical groups

Dr. Atkins' primary practice is Wilkes Medical Center in North Wilkesboro, North Carolina, part of Advocate Health. Dr. Atkins is also affiliated with Bristol Regional Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Atkins to 3 more hospitals and 1 medical group, each named with a free account.

See all 7 affiliations for Dr. Atkins

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. James Norman Atkins' practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Atkins practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Wilkes Medical CenterAvailable with a free account
+4 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Atkins practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Advocate Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. James Norman Atkins is one of 420 hematologists and oncologists in North Carolina

Hematology and oncology is Dr. Atkins' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Atkins is licensed in North Carolina.

Specialties and state licenses

  • Hematology and oncology, North CarolinaPrimaryLicense 22209 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Atkins

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. James Norman Atkins billed Medicare for 528 services in 2024

CMS data shows 528 Medicare services from Dr. Atkins across 5 procedure codes in 2024, all of them office visits, for 246 Medicare patients. Medicare paid $34,074 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024528
Medicare patients246
Paid by Medicare$34,074
Procedure codes5

Dr. Atkins' Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6172024: 52814%

Dr. Atkins compared with the North Carolina median for hematologists and oncologists, 2024

  • Dr. Atkins
  • North Carolina median
Medicare services
528vs 45017% above
Medicare patients
246vs 18037% above
Part D claims
805vs 3242.5 times

Medians across 402 hematologists and oncologists in North Carolina with Dmand AI profiles that report each measure.

Dr. Atkins' most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Atkins

Need commercial claims for Dr. Atkins?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Atkins and other hematologists and oncologists in North Carolina.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. James Norman Atkins treated 246 Medicare patients in 2024, average age 75

CMS counts 246 Medicare patients who saw Dr. Atkins in 2024. The largest group is 75 to 84, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Atkins' median patient age at 73, with 76% women.

Medicare patients, 2024246
Average age75
Average risk score2.08
Also on Medicaid20%

Dr. Atkins' Medicare patients by age, 2024

Dr. Atkins' Medicare patients by sex, 2024

  • Women14860%
  • Men9840%

Chronic conditions among Dr. Atkins' Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer46%
  4. Arthritis44%
  5. Chronic kidney disease39%
  6. Diabetes37%
  7. Mood disorders30%
  8. Depression29%

Share of Medicare patients with each condition. A patient can have several.

Dr. Atkins' patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women76%
  • Men24%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. James Norman Atkins wrote 1,041 Medicare Part D claims in 2024

In 2024, Dr. Atkins wrote 1,041 Medicare Part D claims for 223 patients. 82% of them were for generic drugs. CMS names the drug for 805 of them, across 29 drugs with 11 or more claims each, at $1,688,122 in total drug cost. In 2023, CMS named 784 claims across 24 drugs.

Part D claims, 20241,041
Drugs named by CMS29
Total drug cost$1.7M
Part D patients223

Dr. Atkins' Part D claims by kind of drug, 2024

  • Generic850 claims82%
  • Brand-name191 claims18%

Dr. Atkins' most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Atkins' Part D claims, 2024

  • Opioids8%85 of 1,041 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 7842024: 8053%

Drugs named by CMS: 29 in 2024, 24 in 2023.

See all prescribing by Dr. Atkins

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. James Norman Atkins takes part in Medicare

Dr. Atkins accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Atkins by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. James Norman Atkins has 37 publications on record

Dmand AI links 37 papers to Dr. Atkins, published from 2010 to 2022. 2019 was the busiest year, with 6. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Colonic Neoplasms and Adenocarcinoma. Dr. Atkins has published most often in Cancer Genomics Proteomics. Dr. Atkins' most frequent co-authors are Norman Wolmark, MD, Charles David Blanke, MD and Eleftherios P. Mamounas, MD.

Papers37
Years published2010 to 2022

Dr. Atkins' papers by year, 2012 to 2022

Topics Dr. Atkins writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • Colonic Neoplasms
  • Adenocarcinoma
  • Bevacizumab
  • Biomarkers, Tumor
  • Fluorouracil
  • Gene Expression Regulation, Neoplastic
  • Leucovorin

Dr. Atkins' most frequent co-authors

Recent publications by Dr. Atkins

See all 37 publications and co-authors

See who Dr. Atkins researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Atkins works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. James Norman Atkins has worked on 10 clinical trials

Dmand AI links Dr. Atkins to 10 clinical trials, 7 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Breast Carcinoma In Situ, Breast Neoplasms and Melanoma. National Cancer Institute (NCI) sponsors the most, 7.

Clinical trials with Dr. Atkins by phase

  1. NonePhase 1: no trials
  2. 1Phase 1/2: 1 trial
  3. NonePhase 2: no trials
  4. 1Phase 2/3: 1 trial
  5. 7Phase 3: 7 trials
  6. NonePhase 4: no trials

Trials with no phase (devices, behavioral studies) are left out.

Conditions in Dr. Atkins' trials

  • Breast Carcinoma In Situ
  • Breast Neoplasms
  • Melanoma
  • Breast Diseases
  • Nevi and Melanomas

Investigators on the most trials with Dr. Atkins

Recent clinical trials with Dr. Atkins

See all 10 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. James Norman Atkins received $2,102 in industry payments from 2016 to 2024

CMS Open Payments shows 83 general payments to Dr. Atkins from 31 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 75% of the total. Bristol-Myers Squibb Company paid the most, $253.

General payments to Dr. Atkins by program year, 2016 to 2024

General payments to Dr. Atkins by kind, 2016 to 2024

$2.1Kin total
  • Food and beverage$1,57175%
  • Education$53125%

Companies that paid Dr. Atkins the most, 2016 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Atkins

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. James Norman Atkins's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. James Norman Atkins

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. James Norman Atkins' NPI number?

Dr. James Norman Atkins' NPI number is 1104808476. It was assigned on November 14, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. James Norman Atkins?

Dr. James Norman Atkins is a hematologist and oncologist in North Wilkesboro, North Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. James Norman Atkins practice?

Dr. Atkins practices at 1370 West D St, North Wilkesboro, NC 28659. Dr. Atkins' primary practice is Wilkes Medical Center in North Wilkesboro, North Carolina, part of Advocate Health. Dmand AI also links Dr. Atkins to 3 hospitals and 1 medical group.

What is Dr. James Norman Atkins' office phone number?

The practice phone on file for Dr. Atkins is (336) 651-8100.

What is Dr. James Norman Atkins' medical license number?

Dr. Atkins holds North Carolina license 22209.

Which hospitals is Dr. James Norman Atkins affiliated with?

Dr. Atkins practices at Wilkes Medical Center in North Wilkesboro, North Carolina. Dr. Atkins is also affiliated with Bristol Regional Medical Center. Dmand AI links Dr. Atkins to 3 more hospitals.

What medical group is Dr. James Norman Atkins part of?

Dr. Atkins is linked to Atrium Health Wake Forest Baptist. Dmand AI links Dr. Atkins to 1 more medical group.

Does Dr. James Norman Atkins accept Medicare?

Yes. CMS data shows Dr. Atkins billed Medicare for 528 services in 2024, and Dr. Atkins accepts Medicare assignment.

How many Medicare patients does Dr. James Norman Atkins see?

CMS counts 246 Medicare patients who saw Dr. Atkins in 2024, with an average age of 75.

What services does Dr. James Norman Atkins bill to Medicare?

In 2024, Dr. Atkins' most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and office visit, established patient (99215).

Show 5 more questionsShow fewer questions

What drugs does Dr. James Norman Atkins prescribe most?

In 2024 Medicare Part D data, Dr. Atkins' most prescribed drugs by claims were Anastrozole, Ondansetron HCl and Prochlorperazine Maleate.

Has Dr. James Norman Atkins received payments from drug or device companies?

CMS Open Payments shows $2,102 in general payments to Dr. Atkins from 31 companies from 2016 to 2024. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. James Norman Atkins been practicing?

Dr. Atkins graduated from medical school in 1976, 50 years ago.

Does Dr. James Norman Atkins do research?

Dmand AI links 37 publications to Dr. Atkins, published from 2010 to 2022. Dr. Atkins has worked on 10 clinical trials.

Who does Dr. James Norman Atkins publish with?

Dr. Atkins' most frequent co-authors are Norman Wolmark, MD (11 shared papers), Charles David Blanke, MD (8 shared papers) and Eleftherios P. Mamounas, MD (8 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in North Carolina by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)